Patents by Inventor Alan Wickenden

Alan Wickenden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130310324
    Abstract: The present invention relates to Huwentoxin-IV variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: March 15, 2013
    Publication date: November 21, 2013
    Applicant: JANSSEN BIOTECH, INC.
    Inventors: Mack Flinspach, Michael Hunter, Yi Liu, Robert Neff, Alan Wickenden, Alan Gibbs
  • Patent number: 7355009
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of hElk, antibodies to hElk, methods of detecting hElk, methods of screening for voltage-gated potassium channel activators and inhibitors using biologically active hElk, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising hElk.
    Type: Grant
    Filed: October 15, 2004
    Date of Patent: April 8, 2008
    Assignee: Icagen, Inc.
    Inventors: Timothy J. Jegla, Alan Wickenden
  • Patent number: 7351553
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of BK beta 2, BK beta 3, and BK beta 4, antibodies to the BK beta subunits, methods of detecting the BK beta subunits, methods of screening for modulators of Slo potassium channels comprising BK beta subunits, and kits for screening for activators and inhibitors of the Slo family potassium channels comprising BK beta subunits.
    Type: Grant
    Filed: September 2, 2005
    Date of Patent: April 1, 2008
    Assignee: Icagen, Inc.
    Inventors: Timothy James Jegla, Alan Wickenden, Yi Liu
  • Patent number: 6994968
    Abstract: The invention provides isolated nucleic acid and amino sequences of BK beta 2, BK beta 3, and BK beta 4, antibodies to the BK beta subunits, methods of detecting the BK beta subunits, methods of screening for modulators of Slo family potassium channels comprising BK beta subunits.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: February 7, 2006
    Assignee: Icagen, Inc.
    Inventors: Timothy James Jegla, Alan Wickenden, Yi Liu
  • Publication number: 20060004187
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of BK beta 2, BK beta 3, and BK beta 4, antibodies to the BK beta subunits, methods of detecting the BK beta subunits, methods of screening for modulators of Slo potassium channels comprising BK beta subunits, and kits for screening for activators and inhibitors of the Slo family potassium channels comprising BK beta subunits.
    Type: Application
    Filed: September 2, 2005
    Publication date: January 5, 2006
    Applicant: ICAGEN, INC.
    Inventors: Timothy Jegla, Alan Wickenden, Yi Liu
  • Publication number: 20050227250
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of hElk, antibodies to hElk, methods of detecting hElk, methods of screening for voltage-gated potassium channel activators and inhibitors using biologically active hElk, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising hElk.
    Type: Application
    Filed: October 15, 2004
    Publication date: October 13, 2005
    Applicant: ICAGEN INCORPORATED
    Inventors: Timothy Jegla, Alan Wickenden
  • Patent number: 6833440
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of hElk, antibodies to hElk, methods of detecting hElk, methods of screening for voltage-gated potassium channel activators and inhibitors using biologically active hElk, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising hElk.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: December 21, 2004
    Assignee: Icagen, Incorporated
    Inventors: Timothy J. Jegla, Alan Wickenden
  • Publication number: 20030077731
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of hElk, antibodies to hElk, methods of detecting hElk, methods of screening for voltage-gated potassium channel activators and inhibitors using biologically active hElk, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising hElk.
    Type: Application
    Filed: May 28, 2002
    Publication date: April 24, 2003
    Applicant: ICAgen, Incorporated
    Inventors: Timothy J. Jegla, Alan Wickenden
  • Publication number: 20020169161
    Abstract: Compounds which are useful as potassium channel inhibitors and which because of their slow off-rates are especially useful for the treatment of cardiac arrhythmias are described.
    Type: Application
    Filed: July 24, 2001
    Publication date: November 14, 2002
    Inventors: Serge Beaudoin, Michael F. Gross, Aimee D. Reed, Alan Wickenden, Anrou Zou
  • Patent number: 6432645
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of BK beta 2, BK beta 3, and BK beta 4, antibodies to the BK beta subunits, methods of detecting the BK beta subunits, methods of screening for modulators of Slo potassium channels comprising BK beta subunits, and kits for screening for activators and inhibitors of the Slo family potassium channels comprising BK beta subunits.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: August 13, 2002
    Assignee: ICAgen Inc.
    Inventors: Timothy J. Jegla, Alan Wickenden, Yi Liu
  • Patent number: 6413741
    Abstract: The invention provides isolated nucleic acid and amino acid sequences of hElk, antibodies to hElk, methods of detecting hElk, methods of screening for voltage-gated potassium channel activators and inhibitors using biologically active hElk, and kits for screening for activators and inhibitors of voltage-gated potassium channels comprising hElk.
    Type: Grant
    Filed: June 30, 1999
    Date of Patent: July 2, 2002
    Assignee: ICAgen, Incorporated
    Inventors: Timothy J. Jegla, Alan Wickenden